Health & Fitness

Scientists have long tried to introduce genetically engineered bacteria into the gut to treat diseases. In the past, these attempts have focused on engineering common lab strains of E. coli, which cannot compete with the native gut bacteria that are well adapted to their host. Now, a group of researchers successfully engineered E. coli collected from both human and mice gut microbiomes and showed that they have the potential to treat diseases such as diabetes.

from Top Health News -- ScienceDaily https://ift.tt/u8ZiXIh

Developments in abortion rights in Australia continue to surface in light of the recent changes in accessibility to abortion services in the United States. The latest change see the ACT introduce access to free, safe medical and surgical abortions to all residents of the state.  

from Health | body+soul https://ift.tt/RbQZ1fC

For the first time, scientists have designed a phage combination therapy that can precisely target and suppress gut bacteria associated with inflammatory bowel diseases (IBD). The work showcases the possibility of using phages for treating diseases associated with gut microbiota.

from Top Health News -- ScienceDaily https://ift.tt/u9C5Q6y

Researchers have built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.

from Top Health News -- ScienceDaily https://ift.tt/CqYsthF

Although Aduhelm, a monoclonal antibody targeting amyloid beta (A?), recently became the first US FDA approved drug for Alzheimer's disease (AD) based on its ability to decrease A? plaque burden in AD patients, its effect on cognitive improvement is still controversial. Moreover, about 40% of the patients treated with this antibody experienced serious side effects including cerebral edemas (ARIA-E) and hemorrhages (ARIA-H) that are likely related to inflammatory responses in the brain when the A? antibody binds Fc receptors (FCR) of immune cells such as microglia and macrophages. Now there is a new option.

from Top Health News -- ScienceDaily https://ift.tt/LohxdWs

In a potential game changer for patients with type 2 diabetes, a team of researchers has identified a therapeutic target for the preservation and regeneration of beta cells -- cells in the pancreas that produce and distribute insulin.

from Top Health News -- ScienceDaily https://ift.tt/VfR6BrU